| 10224078
|
Identification and characterization of human rhinovirus-14 3C protease deamidation isoform. |
J Biol Chem |
1999 |
Cox GA;Johnson RB;Cook JA;Wakulchik M;Johnson MG;Villarreal EC;Wang QM |
View
More |
| 10794684
|
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation. |
J Med Chem |
2000 |
Reich SH;Johnson T;Wallace MB;Kephart SE;Fuhrman SA;Worland ST;Matthews DA;Hendrickson TF;Chan F;Meador J 3rd;Ferre RA;Brown EL;DeLisle DM;Patick AK;Binford SL;Ford CE |
View
More |
| 10813815
|
Conservation of polar residues as hot spots at protein interfaces. |
Proteins |
2000 |
Hu Z;Ma B;Wolfson H;Nussinov R |
View
More |
| 10867028
|
2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. |
J Biol Chem |
2000 |
Seipelt J;Liebig HD;Sommergruber W;Gerner C;Kuechler E |
View
More |
| 10950388
|
Antiviral therapy for enteroviruses and rhinoviruses. |
Antivir Chem Chemother |
2000 |
Rotbart HA |
View
More |
| 11118371
|
Complete nucleotide sequence of the chiba virus genome and functional expression of the 3C-like protease in Escherichia coli. |
Virology |
2000 |
Someya Y;Takeda N;Miyamura T |
View
More |
| 11162821
|
Activation of human rhinovirus-14 3C protease. |
Virology |
2001 |
Wang QM;Johnson RB |
View
More |
| 11911365
|
Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C. |
RNA |
2002 |
Zell R;Sidigi K;Bucci E;Stelzner A;Gorlach M |
View
More |
| 12370021
|
Inhibition of cysteine protease activity by NO-donors. |
Curr Protein Pept Sci |
2001 |
Ascenzi P;Salvati L;Bolognesi M;Colasanti M;Polticelli F;Venturini G |
View
More |
| 15080921
|
Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design. |
Bioorg Med Chem |
2004 |
Zhang XW;Yap YL |
View
More |
| 1658106
|
Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay. |
J Biochem Biophys Methods |
1991 |
Hopkins JL;Betageri R;Cohen KA;Emmanuel MJ;Joseph CR;Bax PM;Pallai PV;Skoog MT |
View
More |
| 16759084
|
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. |
J Med Chem |
2006 |
Zhou L;Liu Y;Zhang W;Wei P;Huang C;Pei J;Yuan Y;Lai L |
View
More |
| 17007846
|
Defining residues involved in human rhinovirus 2A proteinase substrate recognition. |
FEBS Lett |
2006 |
Sousa C;Schmid EM;Skern T |
View
More |
| 17305557
|
Human rhinovirus 3C protease as a potential target for the development of antiviral agents. |
Curr Protein Pept Sci |
2007 |
Wanga QM;Chen SH |
View
More |
| 18583140
|
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. |
Bioorg Med Chem |
2008 |
Kuo CJ;Shie JJ;Fang JM;Yen GR;Hsu JT;Liu HG;Tseng SN;Chang SC;Lee CY;Shih SR;Liang PH |
View
More |
| 19268541
|
A picornaviral loop-to-loop replication complex. |
J Struct Biol |
2009 |
Claridge JK;Headey SJ;Chow JY;Schwalbe M;Edwards PJ;Jeffries CM;Venugopal H;Trewhella J;Pascal SM |
View
More |
| 21543871
|
Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor. |
Acta Crystallogr Sect F Struct Biol Cryst Commun |
2011 |
Amacher JF;Cushing PR;Weiner JA;Madden DR |
View
More |
| 21664926
|
Homology modeling, docking, molecular dynamics simulation, and structural analyses of coxsakievirus B3 2A protease: an enzyme involved in the pathogenesis of inflammatory myocarditis. |
Int J Biol Macromol |
2011 |
Maghsoudi AH;Khodagholi F;Hadi-Alijanvand H;Esfandiarei M;Sabbaghian M;Zakeri Z;Shaerzadeh F;Abtahi S;Maghsoudi N |
View
More |
| 23388726
|
3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. |
J Virol |
2013 |
Tan J;George S;Kusov Y;Perbandt M;Anemuller S;Mesters JR;Norder H;Coutard B;Lacroix C;Leyssen P;Neyts J;Hilgenfeld R |
View
More |
| 24125888
|
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. |
Bioorg Med Chem Lett |
2013 |
Prior AM;Kim Y;Weerasekara S;Moroze M;Alliston KR;Uy RA;Groutas WC;Chang KO;Hua DH |
View
More |
| 25350699
|
Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting. |
Bioconjug Chem |
2014 |
Stefan N;Zimmermann M;Simon M;Zangemeister-Wittke U;Pluckthun A |
View
More |
| 25792507
|
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study. |
J Enzyme Inhib Med Chem |
2016 |
Ang MJ;Lau QY;Ng FM;Then SW;Poulsen A;Cheong YK;Ngoh ZX;Tan YW;Peng J;Keller TH;Hill J;Chu JJ;Chia CS |
View
More |
| 28217559
|
A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity. |
Front Cell Infect Microbiol |
2017 |
Li B;Yue Y;Zhang Y;Yuan Z;Li P;Song N;Lin W;Liu Y;Gu L;Meng H |
View
More |
| 28801725
|
Optimization of Soluble Expression and Purification of Recombinant Human Rhinovirus Type-14 3C Protease Using Statistically Designed Experiments: Isolation and Characterization of the Enzyme. |
Mol Biotechnol |
2017 |
Antoniou G;Papakyriacou I;Papaneophytou C |
View
More |
| 30118570
|
Building and Breaking Bonds via a Compact S-Propargyl-Cysteine to Chemically Control Enzymes and Modify Proteins. |
Angew Chem Int Ed Engl |
2018 |
Liu J;Cheng R;Wu H;Li S;Wang PG;DeGrado WF;Rozovsky S;Wang L |
View
More |
| 31117169
|
Design of a Human Rhinovirus-14 3C Protease-Inducible Caspase-3. |
Molecules |
2019 |
Wagner HJ;Weber W |
View
More |
| 32619644
|
Covalent and non-covalent strategies for the immobilization of Tobacco Etch Virus protease (TEVp) on superparamagnetic nanoparticles. |
J Biotechnol |
2020 |
Norris JL;Patel T;Dasari AKR;Cope TA;Lim KH;Hughes RM |
View
More |
| 34230602
|
A split protease-E. coli ClpXP system quantifies protein-protein interactions in Escherichia coli cells. |
Commun Biol |
2021 |
Wang S;Zhang F;Mei M;Wang T;Yun Y;Yang S;Zhang G;Yi L |
View
More |
| 34626801
|
Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies. |
Protein Expr Purif |
2022 |
Cantrell MS;Wall JD;Pu X;Turner M;Woodbury L;Fujise K;McDougal OM;Warner LR |
View
More |
| 7794931
|
Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase. |
Biochemistry |
1995 |
Malcolm BA;Lowe C;Shechosky S;McKay RT;Yang CC;Shah VJ;Simon RJ;Vederas JC;Santi DV |
View
More |
| 8761474
|
Human rhinovirus 2A proteinase mutant and its second-site revertants. |
Biochem J |
1996 |
Luderer-Gmach M;Liebig HD;Sommergruber W;Voss T;Fessl F;Skern T;Kuechler E |
View
More |
| 8978838
|
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. |
J Med Chem |
1996 |
Webber SE;Tikhe J;Worland ST;Fuhrman SA;Hendrickson TF;Matthews DA;Love RA;Patick AK;Meador JW;Ferre RA;Brown EL;DeLisle DM;Ford CE;Binford SL |
View
More |
| 9445078
|
Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. |
J Virol |
1998 |
Wang QM;Johnson RB;Cox GA;Villarreal EC;Churgay LM;Hale JE |
View
More |
| 9667969
|
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. |
J Med Chem |
1998 |
Webber SE;Okano K;Little TL;Reich SH;Xin Y;Fuhrman SA;Matthews DA;Love RA;Hendrickson TF;Patick AK;Meador JW 3rd;Ferre RA;Brown EL;Ford CE;Binford SL;Worland ST |
View
More |
| 9667970
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Reich SH;Prins TJ;Marakovits JT;Littlefield ES;Zhou R;Tikhe J;Ford CE;Wallace MB;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;Harr JE;DeLisle DM;Worland ST |
View
More |
| 9667971
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Reich SH;Marakovits JT;Prins TJ;Zhou R;Tikhe J;Littlefield ES;Bleckman TM;Wallace MB;Little TL;Ford CE;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;DeLisle DM;Worland ST |
View
More |
| 9681985
|
Development of in vitro peptide substrates for human rhinovirus-14 2A protease. |
Arch Biochem Biophys |
1998 |
Wang QM;Johnson RB;Sommergruber W;Shepherd TA |
View
More |
